SUS
Surgical Science
Stock
Stock
ISIN: SE0014428512
Ticker: SUS
SE0014428512
SUS
Price
Price
CHART BY
Frequently asked questions
What is Surgical Science's market capitalization?
The market capitalization of Surgical Science is $763.57M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Surgical Science's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Surgical Science is 61.78. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Surgical Science?
Surgical Science's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.242. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Surgical Science's stock?
Currently, 5 analysts cover Surgical Science's stock, with a consensus target price of $19.01. Analyst ratings provide insights into the stock's expected performance.
What is Surgical Science's revenue over the trailing twelve months?
Over the trailing twelve months, Surgical Science reported a revenue of $83.00M.
What is the EBITDA for Surgical Science?
Surgical Science's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $19.71M. EBITDA measures the company's overall financial performance.
How many employees does Surgical Science have, and what sector and industry does it belong to?
Surgical Science employs approximately 274 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Surgical Science's shares?
The free float of Surgical Science is 34.88M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $763.57M
- EPS (TTM)
- $0.242
- Free Float
- 34.88M
- P/E ratio (TTM)
- 61.78
- Revenue (TTM)
- $83.00M
- EBITDA (TTM)
- $19.71M
Pricing
- 1D span
- $14.75$15.57
- 52W span
- $10.48$17.99
Analyst Ratings
The price target is $19.01 and the stock is covered by 5 analysts.
Buy
4
Hold
1
Sell
0
Information
Surgical Science Sweden AB engages in the development of simulators for laparoscopic medical training. Its products include LapSim, for procedural simulation for cholecystectomy, appendectomy, advanced suturing and anastomosis, gynecology, hysterectomy, bariatrics, and nephrectomy; EndoSim, for endoscopy simulation; and TeamSim, for realistic training of collaboration within a surgery team. The company was founded by Anders Hyltander, David Löfstrand, and Anders Larsson on July 24, 1997 and is headquartered in Gothenburg, Sweden.
- Employees
- 274
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- SE0014428512
- Primary Ticker
- SUS
Knockouts
Finance data from FactSet